Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma
Year: 2018
Type: article
Source: British Journal of Haematology
DOI: 10.1111/bjh.15716
Institution: Levine Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Sanofi, Array BioPharma, Pharmacyclics
OpenAlex ID: W2903721846
